Invitation to Revenio’s audiocast and teleconference in relation to the half-year financial report 2021
Revenio Group Corporation’s half-year financial report 2021 on Thursday, 5 August 2021, approximately at 9:00 am.
An audiocast and teleconference for analytics and investors is held in English at 3:00 pm on the same day.
Link to the event: https://revenio.videosync.fi/2021-08-05-revenioq2
FI: +358 981710310
SE: +46 856642651
UK: +44 3333000804
US: +1 6319131422
For further information, please contact:
Robin Pulkkinen, CFO, tel. +358 50 505 9932
Revenio Group in brief
Revenio is a leading company in ophthalmological devices and software solutions. Revenio Group’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), retinal imaging devices, and perimeters under the iCare brand. In addition, the Group’s eye care software platform Oculo brings together clinical communication, telehealth, remote patient monitoring, and data analytics capabilities.
Revenio Group comprises Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Revenio Australia Pty Ltd, Done Medical Oy and Oscare Medical Oy.
In 2020, the Group’s net sales totaled EUR 61.1 million and its operating profit amounted to EUR 17.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.